Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform
Karine Rossignol, Co-founder and Chief Executive Officer of Smart Immune, will give an introduction to Smart Immune and its ProTcell platform.
- Karine Rossignol, Co-founder and Chief Executive Officer of Smart Immune, will give an introduction to Smart Immune and its ProTcell platform.
- Marina Cavazzana, Co-founder and Strategic Clinical Development Advisor of Smart Immune, will present the ReSET-01 and ReSET-02 trials, including preliminary results in adult acute leukemia patients.
- Marcel Van den Brink, President of the City of Hope Los Angles National Medical Center and Chief Physician Executive, and Smart Immune’s Scientific Advisory Board Chairman, will discuss the importance of thymic function in the immune system.
- Olivier Negre, Chief Scientific Officer of Smart Immune, will outline preclinical data on the regenerative properties of ProTcell and its potential to unlock allogeneic T-cell medicine.